bosentan anhydrous has been researched along with Coronary Artery Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouras, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Kaoukis, A; Panagopoulou, V; Papoutsidakis, N; Raisakis, K; Stefanadis, C | 1 |
| Bengtsson, M; Kalani, M; Papadogeorgos, NO | 1 |
| Held, M; Jany, BH | 1 |
| Breu, V; Clozel, JP; Clozel, M; Dagassan, PH; Kiowski, W; Künzli, A; Turina, M; Vogt, P | 1 |
| Kosaka, H; Morita, H; Murakami, H; Nishida, Y; Okada, K; Okada, M; Sugimoto, I; Yamashita, C | 1 |
1 review(s) available for bosentan anhydrous and Coronary Artery Disease
| Article | Year |
|---|---|
The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition.
Topics: Animals; Atherosclerosis; Atrial Fibrillation; Bosentan; Cardiovascular Diseases; Coronary Artery Disease; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Hypertension, Pulmonary; Phenylpropionates; Predictive Value of Tests; Pyridazines; Receptors, Endothelin; Sulfonamides | 2013 |
1 trial(s) available for bosentan anhydrous and Coronary Artery Disease
| Article | Year |
|---|---|
Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.
Topics: Aged; Angioplasty, Balloon, Coronary; Bosentan; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Endothelin A Receptor Antagonists; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Peptides, Cyclic; Receptor, Endothelin A; Stents; Sulfonamides; Treatment Outcome | 2009 |
3 other study(ies) available for bosentan anhydrous and Coronary Artery Disease
| Article | Year |
|---|---|
Pulmonary hypertension in COPD.
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Bosentan; Comorbidity; Coronary Artery Disease; Exercise Test; Female; Humans; Hypertension, Pulmonary; Male; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Sulfonamides; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2013 |
Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries.
Topics: Acetylcholine; Adult; Bosentan; Coronary Artery Disease; Endothelin Receptor Antagonists; Humans; Middle Aged; Peptides, Cyclic; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides; Up-Regulation; Vasoconstrictor Agents; Viper Venoms | 1996 |
Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist.
Topics: Actins; Animals; Antihypertensive Agents; Bosentan; Coronary Artery Disease; Endothelin-1; Endothelium, Vascular; Graft Survival; Heart Transplantation; Male; Rats; Rats, Inbred Lew; Staining and Labeling; Sulfonamides; Transplantation, Homologous | 1998 |